All News about Cybin Inc
Cybin (NEO: CYBN) (NYSE American: CYBN) Receives Notice of Allowance from U.S. Patent Office
December 15, 2021
Topics
Intellectual Property
Exposures
Intellectual Property
![]() ![]() ![]() ![]()
Psilera's DMT-Derived Drug Sees Positive Results in Pre-Clinical Study
December 09, 2021
Via Benzinga
Topics
Derivatives
Exposures
Derivatives
![]() ![]() ![]() ![]()
Cybin Announces FDA Approvals, Participation in Conference
December 01, 2021
Via Benzinga
Exposures
Product Safety
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|